Dementia: Pharmacists to explore how to enhance patient care in upcoming webinar

Dementia and Alzheimer’s disease remained the leading cause of death in England and Wales in 2023, maintaining the pre-pandemic trend, according to the
latest data from the Office for National Statistics (ONS).

The figures reveal that there were 66,876 deaths with an underlying cause of dementia and Alzheimer’s disease, accounting for 11.6% of all deaths registered that
year.

In response to this growing health concern, Luye Pharma is hosting a free special educational webinar on 6 November 2024 (timing: 18:30 – 20:00) for healthcare
professionals.

Titled “Treating Dementia in 2024: Optimising Pathways Between Primary and Secondary Care,” the online session will focus on addressing the ever-increasing
challenges in dementia treatment and how to optimise pathways between primary and secondary care.

The webinar will feature expert speakers from the field of dementia care, including Dr. Jill Rasmussen, Primary Care Specialist in dementia, mental health, and
intellectual disabilities; Delia Bashara, Consultant Pharmacist for the Mental Health of Older Adults and Dementia at South London and Maudsley NHS Foundation
Trust; and Khaleel Loonat, Senior Clinical Pharmacist and Advanced Clinical Practitioner.